Apart from these regulatory activities, GLUTs can be regulated by several miRNAs, and the GLUT-targeting miRNAs are thought to be downregulated to favor various cancer types including ovarian cancer, lung cancer, colon cancer, bladder cancer, prostate cancer, and renal cell carcinoma (Figure 1). Here, SLC2A1 is linked to renal cell carcinoma.